Difference between revisions of "Mutual Recognition Agreements"
STUART KING (talk | contribs) |
STUART KING (talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | [[Globalisation: European Commission and the Pharmaceutical Industry]] | + | As part of [[Globalisation: European Commission and the Pharmaceutical Industry]] |
| − | This is the activity of European Commission whereby in the context of the EU pharmaceutical industry, MRAs faciliate the international trading of pharmaceutical products. Essentially, MRAs set out the conditions between the EU and other countries in the trading and promoting of pharmaceuticals. The Commission's pharmaceutical unit play an important role in actively promoting the trading of such products between the EU and countries on a global scale, e.g. Canada, the US, Australia, New Zealand, Switzerland and Japan. <ref> | + | This is the activity of European Commission whereby in the context of the EU pharmaceutical industry, MRAs faciliate the international trading of pharmaceutical products. Essentially, MRAs set out the conditions between the EU and other countries in the trading and promoting of pharmaceuticals. The Commission's pharmaceutical unit play an important role in actively promoting the trading of such products between the EU and countries on a global scale, e.g. Canada, the US, Australia, New Zealand, Switzerland and Japan. <ref> European Commission [http://ec.europa.eu/enterprise/pharmaceuticals/mra/index.htm MRA] Accessed 1/03/08 </ref> <ref> European Commission [http://ec.europa.eu/enterprise/international/index_en.htm Mutual recognition agreements] Accessed 1/03/08 </ref> <ref> European Commission [http://ec.europa.eu/enterprise/pharmaceuticals/mra/doc/statusreport20030717 Pharmaceuticals: regulatory framework and market authorisations.pdf] Accessed 1/03/08 </ref> |
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
Revision as of 12:36, 25 March 2008
As part of Globalisation: European Commission and the Pharmaceutical Industry
This is the activity of European Commission whereby in the context of the EU pharmaceutical industry, MRAs faciliate the international trading of pharmaceutical products. Essentially, MRAs set out the conditions between the EU and other countries in the trading and promoting of pharmaceuticals. The Commission's pharmaceutical unit play an important role in actively promoting the trading of such products between the EU and countries on a global scale, e.g. Canada, the US, Australia, New Zealand, Switzerland and Japan. [1] [2] [3]
Notes
- ↑ European Commission MRA Accessed 1/03/08
- ↑ European Commission Mutual recognition agreements Accessed 1/03/08
- ↑ European Commission Pharmaceuticals: regulatory framework and market authorisations.pdf Accessed 1/03/08
